BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 15776372)

  • 21. The effect of meningococcal group A and C polysaccharide vaccine on nasopharyngeal carrier state.
    Stroffolini T; Angelini L; Galanti I; Occhionero M; Congiu ME; Mastrantonio P
    Microbiologica; 1990 Jul; 13(3):225-9. PubMed ID: 2125684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased genetic diversity of Neisseria meningitidis isolates after the introduction of meningococcal serogroup C polysaccharide conjugate vaccines.
    Diggle MA; Clarke SC
    J Clin Microbiol; 2005 Sep; 43(9):4649-53. PubMed ID: 16145121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine.
    Bårnes GK; Kristiansen PA; Beyene D; Workalemahu B; Fissiha P; Merdekios B; Bohlin J; Préziosi MP; Aseffa A; Caugant DA
    BMC Infect Dis; 2016 Nov; 16(1):639. PubMed ID: 27814682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Young-adult carriers of Neisseria meningitidis in Puglia (Italy): will the pattern of circulating meningococci change following the introduction of meningococcal serogroup C conjugate vaccines?
    Germinario C; Tafuri S; Napoli C; Montagna MT; Balducci MT; Fortunato F; Martinelli D; Prato R
    Hum Vaccin; 2010 Dec; 6(12):1025-7. PubMed ID: 21150271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase of Neisseria meningitidis W:cc11 invasive disease in Chile has no correlation with carriage in adolescents.
    Rubilar PS; Barra GN; Gabastou JM; Alarcón P; Araya P; Hormazábal JC; Fernandez J
    PLoS One; 2018; 13(3):e0193572. PubMed ID: 29518095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Meningococcal disease: are patients carriers of meningococci after treatment with antibiotics?].
    Weis NM; Lind I
    Ugeskr Laeger; 1990 May; 152(19):1362-5. PubMed ID: 2111593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa.
    Ganesh K; Allam M; Wolter N; Bratcher HB; Harrison OB; Lucidarme J; Borrow R; de Gouveia L; Meiring S; Birkhead M; Maiden MC; von Gottberg A; du Plessis M
    BMC Microbiol; 2017 Feb; 17(1):40. PubMed ID: 28222677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation.
    Ibarz-Pavón AB; Maclennan J; Andrews NJ; Gray SJ; Urwin R; Clarke SC; Walker AM; Evans MR; Kroll JS; Neal KR; Ala'aldeen D; Crook DW; Cann K; Harrison S; Cunningham R; Baxter D; Kaczmarski E; McCarthy ND; Jolley KA; Cameron JC; Stuart JM; Maiden MC
    J Infect Dis; 2011 Oct; 204(7):1046-53. PubMed ID: 21881120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carriage rates and risk factors during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C ST-11 (cc11) in Tuscany, Italy: a cross-sectional study.
    Miglietta A; Innocenti F; Pezzotti P; Riccobono E; Moriondo M; Pecile P; Nieddu F; Rossolini GM; Azzari C; ; Balocchini E; Rezza G; Voller F; Stefanelli P
    BMC Infect Dis; 2019 Jan; 19(1):29. PubMed ID: 30621624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana.
    Gagneux SP; Hodgson A; Smith TA; Wirth T; Ehrhard I; Morelli G; Genton B; Binka FN; Achtman M; Pluschke G
    J Infect Dis; 2002 Mar; 185(5):618-26. PubMed ID: 11865418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.
    Maiden MC; Ibarz-Pavón AB; Urwin R; Gray SJ; Andrews NJ; Clarke SC; Walker AM; Evans MR; Kroll JS; Neal KR; Ala'aldeen DA; Crook DW; Cann K; Harrison S; Cunningham R; Baxter D; Kaczmarski E; Maclennan J; Cameron JC; Stuart JM
    J Infect Dis; 2008 Mar; 197(5):737-43. PubMed ID: 18271745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nasopharyngeal carriage of Neisseria meningitidis among school children at Ijede, Lagos State, Nigeria.
    Odugbemi T; Ademidun O; Agbabiaka A; Banjo T
    Ethiop Med J; 1992 Jan; 30(1):33-6. PubMed ID: 1563362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neisseria meningitidis carriage during an outbreak of serogroup C disease.
    Patrick DM; Champagne S; Goh SH; Arsenault G; Thomas E; Shaw C; Rahim T; Taha F; Bigham M; Dubenko V; Skowronski D; Brunham RC
    Clin Infect Dis; 2003 Nov; 37(9):1183-8. PubMed ID: 14557962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carriage of Neisseria meningitidis and Neisseria lactamica in northern Greece.
    Kremastinou J; Tzanakaki G; Levidiotou S; Markou F; Themeli E; Voyiatzi A; Psoma E; Theodoridou M; Blackwell CC
    FEMS Immunol Med Microbiol; 2003 Oct; 39(1):23-9. PubMed ID: 14556992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease.
    Kellerman SE; McCombs K; Ray M; Baughman W; Reeves MW; Popovic T; Rosenstein NE; Farley MM; Blake P; Stephens DS;
    J Infect Dis; 2002 Jul; 186(1):40-8. PubMed ID: 12089660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic analysis of Canadian isolates of C:2a:P1.2,5 and B:2a:P1.2,5 Neisseria meningitidis strains belonging to the hypervirulent clone of ET-15.
    Tyler S; Tsang R
    Can J Microbiol; 2004 Jun; 50(6):433-43. PubMed ID: 15284889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina Faso.
    Findlow H; Vogel U; Mueller JE; Curry A; Njanpop-Lafourcade BM; Claus H; Gray SJ; Yaro S; Traoré Y; Sangaré L; Nicolas P; Gessner BD; Borrow R
    J Infect Dis; 2007 Apr; 195(7):1071-7. PubMed ID: 17330799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunochemical studies and genetic background of two Neisseria meningitidis isolates expressing unusual capsule polysaccharide antigens with specificities of both serogroup Y and W135.
    Tsang RS; Tsai CM; Henderson AM; Tyler S; Law DK; Zollinger W; Jamieson F
    Can J Microbiol; 2008 Mar; 54(3):229-34. PubMed ID: 18388994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neisseria meningitidis; clones, carriage, and disease.
    Read RC
    Clin Microbiol Infect; 2014 May; 20(5):391-5. PubMed ID: 24766477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular epidemiology of meningococci: application of DNA sequence typing.
    Vogel U
    Int J Med Microbiol; 2010 Nov; 300(7):415-20. PubMed ID: 20537945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.